This may help explain the recent unexpected finding that pharmacological CASP‐1 inhibitors protect against cognitive decline in mouse models of Alzheimer dementia by altering neuronal function rather than modulating inflammation (Flores et al. 2020; Flores et al. 2022). Here, CASP1 is linked to Alzheimer disease.